SCM
Solas Capital Management’s Fennec Pharmaceuticals FENC Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $18.5M | Sell |
2,232,902
-18,017
| -0.8% | -$150K | 10.37% | 2 |
|
2025
Q1 | $13.7M | Hold |
2,250,919
| – | – | 7.71% | 4 |
|
2024
Q4 | $14.2M | Buy |
2,250,919
+327,383
| +17% | +$2.07M | 9.45% | 2 |
|
2024
Q3 | $9.62M | Buy |
1,923,536
+583,536
| +44% | +$2.92M | 6.75% | 7 |
|
2024
Q2 | $8.19M | Buy |
1,340,000
+229,767
| +21% | +$1.4M | 4.48% | 11 |
|
2024
Q1 | $12.3M | Sell |
1,110,233
-268,280
| -19% | -$2.98M | 7.94% | 5 |
|
2023
Q4 | $15.5M | Sell |
1,378,513
-347,054
| -20% | -$3.89M | 9.6% | 2 |
|
2023
Q3 | $13M | Buy |
1,725,567
+286,539
| +20% | +$2.15M | 9.07% | 3 |
|
2023
Q2 | $12.7M | Buy |
1,439,028
+154,485
| +12% | +$1.36M | 8.45% | 2 |
|
2023
Q1 | $10.7M | Buy |
1,284,543
+32,155
| +3% | +$268K | 5.71% | 7 |
|
2022
Q4 | $12M | Buy |
1,252,388
+121,221
| +11% | +$1.16M | 7.21% | 4 |
|
2022
Q3 | $9.16M | Sell |
1,131,167
-42,349
| -4% | -$343K | 5.59% | 5 |
|
2022
Q2 | $6.55M | Buy |
1,173,516
+27,720
| +2% | +$155K | 3.91% | 11 |
|
2022
Q1 | $6.42M | Buy |
1,145,796
+277,939
| +32% | +$1.56M | 3.89% | 12 |
|
2021
Q4 | $3.82M | Hold |
867,857
| – | – | 2.72% | 17 |
|
2021
Q3 | $8.18M | Hold |
867,857
| – | – | 5.69% | 5 |
|
2021
Q2 | $6.33M | Buy |
867,857
+67,857
| +8% | +$495K | 4.44% | 9 |
|
2021
Q1 | $4.97M | Hold |
800,000
| – | – | 4.18% | 9 |
|
2020
Q4 | $5.96M | Hold |
800,000
| – | – | 4.55% | 9 |
|
2020
Q3 | $4.85M | Sell |
800,000
-160,000
| -17% | -$970K | 4.64% | 8 |
|
2020
Q2 | $8.02M | Hold |
960,000
| – | – | 7.4% | 3 |
|
2020
Q1 | $5.7M | Sell |
960,000
-11,795
| -1% | -$70.1K | 6.17% | 5 |
|
2019
Q4 | $6.31M | Buy |
971,795
+28,595
| +3% | +$186K | 6.06% | 6 |
|
2019
Q3 | $4.54M | Buy |
943,200
+93,221
| +11% | +$448K | 4.69% | 10 |
|
2019
Q2 | $3.4M | Buy |
+849,979
| New | +$3.4M | 3.47% | 12 |
|